MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202521015306 A) filed by Rungta International Skills University; Rungta College Of Engineering & Technology; and Rungta College Of Pharmaceutical Sciences And Research on February 22, 2025, for Formulation Of Clitoria Ternatea Hydroalcoholic Extract-Based Topical Cream For Diabetic Wound Healing.
Inventors include Sanjeeta Manu; Dr. Sanjay Kumar Gupta; Sonal Sinha; Jyoti Singh; Ankur Das; Nagma Shahin; Rose Shahin; Jagriti Pisda; and Dolly Borkar.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: Formulation of Clitoria Ternatea Hydroalcoholic Extract-Based Topical Cream for Diabetic Wound Healing This invention describes a topical cream formulated with a hydroalcoholic extract of Clitoria ternatea, optimized for treating diabetic wounds. The cream harnesses the extract's antioxidant and anti-inflammatory properties to address the delayed healing characteristic of diabetic wounds. Key formulation aspects include an adjusted pH of 6.2 to 6.9, a viscosity range of 5904 to 5905 centipoise, and enhanced spreadability, ensuring effective application and therapeutic action. Clinical trials on diabetic rat models demonstrate significant improvements in wound contraction, reduced inflammation, and accelerated tissue repair compared to standard treatments. The invention provides a natural, effective, and safer alternative for diabetic wound management, aiming to improve healing outcomes and patient quality of life.
Disclaimer: Curated by HT Syndication.
